Delivery Order SPE2DB22D2206-SPE2DB24FJA94

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 200 mg/mL syringes to the Defense Logistics Agency (DLA). The $5,774.88 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a completion date of January 8, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML SYRINGE medication to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $5,581.96 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division. There was no set-aside used for this contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML to the U.S. Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order with a ceiling value of $2,793.03. The award has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,586.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $5,581.96 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of BENLYSTA 200 mg/mL syringes, a pharmaceutical product. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR medical products to the Defense Logistics Agency (DLA). The $5,779.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 24, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract, valued at $8,379.09, was awarded by the Defense Logistics Agency (DLA) and has a completion date of May 30, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,790.98 firm fixed-price delivery order is for BENLYSTA 200 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Benlysta 200 mg/ml syringes to the Defense Logistics Agency (DLA). The $2,790.98 delivery order is a firm-fixed price contract with a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract valued at $5,586.06. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJA94
    Delivery Order

This federal contract award is for the delivery of BENLYSTA 200 MG/ML SYRINGE to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $5,581.96, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government.

The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 25, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/2/24, 10:03 AM